Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.

Egan G, Goldman S, Alexander S.

Br J Haematol. 2019 Jun;185(6):1071-1085. doi: 10.1111/bjh.15734. Epub 2019 Jan 6. Review.

PMID:
30613948
2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
3.

Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.

Worch J, Rohde M, Burkhardt B.

Pediatr Hematol Oncol. 2013 Sep;30(6):465-83. doi: 10.3109/08880018.2013.783891. Epub 2013 Apr 9. Review.

PMID:
23570584
4.

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

Giulino-Roth L, Goldman S.

Br J Haematol. 2016 May;173(4):531-44. doi: 10.1111/bjh.13969. Epub 2016 Mar 21. Review. Erratum in: Br J Haematol. 2016 Nov;175(3):547.

PMID:
26996160
5.

The therapeutic use of rituximab in non-Hodgkin's lymphoma.

Marcus R, Hagenbeek A.

Eur J Haematol Suppl. 2007 Jan;(67):5-14. Review.

PMID:
17206982
6.

Non-Hodgkin's lymphoma: the old and the new.

Cabanillas F.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S87-90. doi: 10.1016/j.clml.2011.03.029. Epub 2011 Apr 28. Review.

PMID:
22035756
7.

Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.

Sakarou M, Eisele L, Dührsen U, Hüttmann A.

Eur J Haematol. 2019 Mar;102(3):241-250. doi: 10.1111/ejh.13199. Epub 2019 Jan 20.

PMID:
30471148
8.

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.

Palanca-Wessels MC, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, Patel MR, Sangha R, Hagenbeek A, Advani R, Tilly H, Casasnovas O, Press OW, Yalamanchili S, Kahn R, Dere RC, Lu D, Jones S, Jones C, Chu YW, Morschhauser F.

Lancet Oncol. 2015 Jun;16(6):704-15. doi: 10.1016/S1470-2045(15)70128-2. Epub 2015 Apr 27.

PMID:
25925619
9.

Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.

Reiter A, Klapper W.

Br J Haematol. 2008 Jul;142(3):329-47. doi: 10.1111/j.1365-2141.2008.06988.x. Epub 2008 Jun 3. Review.

PMID:
18537979
10.

Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.

Burkhardt B, Oschlies I, Klapper W, Zimmermann M, Woessmann W, Meinhardt A, Landmann E, Attarbaschi A, Niggli F, Schrappe M, Reiter A.

Leukemia. 2011 Jan;25(1):153-60. doi: 10.1038/leu.2010.245. Epub 2010 Oct 29.

PMID:
21030984
11.

Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.

Qin C, Huang Y, Feng Y, Li M, Guo N, Rao H.

Diagn Pathol. 2018 Feb 27;13(1):17. doi: 10.1186/s13000-018-0693-0.

12.

Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma.

El-Mallawany NK, Cairo MS.

Clin Adv Hematol Oncol. 2015 Feb;13(2):113-23. Review.

PMID:
25774481
13.

Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.

Miles RR, Cairo MS, Satwani P, Zwick DL, Lones MA, Sposto R, Abromovitch M, Tripp S, Angiolillo AL, Roman E, Davenport V, Perkins SL.

Br J Haematol. 2007 Aug;138(4):506-12.

PMID:
17659054
14.

Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.

Galardy PJ, Hochberg J, Perkins SL, Harrison L, Goldman S, Cairo MS.

Br J Haematol. 2013 Nov;163(3):365-72. doi: 10.1111/bjh.12542. Epub 2013 Sep 6.

15.

Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010M.

Maschan A, Myakova N, Aleinikova O, Abugova Y, Ponomareva N, Belogurova M, Fechina L, Fedorova A, Grigor'eva N, Lebedev V, Nikonova O, Shamardina A, Sharapova G, Smirnova N, Rudneva A, Volchkov E, Samochatova E.

Br J Haematol. 2019 May 9. doi: 10.1111/bjh.15944. [Epub ahead of print]

PMID:
31069789
16.

Bendamustine's emerging role in the management of lymphoid malignancies.

Rummel MJ, Gregory SA.

Semin Hematol. 2011 Apr;48 Suppl 1:S24-36. doi: 10.1053/j.seminhematol.2011.03.004. Review.

PMID:
21530769
17.

Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.

Pillon M, Mussolin L, Carraro E, Conter V, Aricò M, Vinti L, Garaventa A, Piglione M, Buffardi S, Sala A, Santoro N, Lo Nigro L, Mura R, Tondo A, Casale F, Farruggia P, Pierani P, Cesaro S, d'Amore ES, Basso G.

Br J Haematol. 2016 Nov;175(3):467-475. doi: 10.1111/bjh.14240. Epub 2016 Jul 8.

PMID:
27392319
18.

Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma.

Prichard M, Harris T, Williams ME, Densmore JJ.

Expert Opin Pharmacother. 2009 Apr;10(6):983-95. doi: 10.1517/14656560902895715 . Review.

PMID:
19364248
19.

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.

Witzig TE, Nowakowski GS, Habermann TM, Goy A, Hernandez-Ilizaliturri FJ, Chiappella A, Vitolo U, Fowler N, Czuczman MS.

Ann Oncol. 2015 Aug;26(8):1667-77. doi: 10.1093/annonc/mdv102. Epub 2015 Feb 23. Review.

PMID:
25712458
20.

Diffuse aggressive lymphoma.

Fisher RI, Miller TP, O'Connor OA.

Hematology Am Soc Hematol Educ Program. 2004:221-36. Review.

PMID:
15561685

Supplemental Content

Support Center